PDF herunterladen
Clin Colon Rectal Surg 2007; 20(1): 013-017
DOI: 10.1055/s-2007-970195
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Clostridium difficile Colitis

Judith L. Trudel1
  • 1Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota, St. Paul, Minnesota
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. Februar 2007 (online)

Auch verfügbar auf
    Lizenzen und Reprints

ABSTRACT

Clostridium difficile enterocolitis is endemic in most modern hospitals. The spectrum of clinical presentation varies from the asymptomatic carrier state to fulminant colitis with toxic megacolon and perforation. Highly toxigenic and lethal strains of C. difficile have emerged worldwide. Medical treatment consists of discontinuing the precipitating antibiotic, supportive measures and bowel rest, and antibiotic treatment with metronidazole or vancomycin. Surgical treatment may be necessary in cases of fulminant disease. Subtotal colectomy with end ileostomy is the operation of choice.

KEYWORDS

Clostridium difficile - pseudomembranous enterocolitis - antibiotic-associated colitis

REFERENCES

  • 1 Rolfe R D, Helebian S, Finegold S M. Bacterial interference between Clostridium difficile and normal fecal flora.  J Infect Dis. 1981;  143 470-475
    PubMedGoogle Scholar
  • 2 Moyenuddin M, Williamson J C, Ohl C A. Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.  Curr Gastroenterol Rep. 2002;  4 279-286
    PubMedGoogle Scholar
  • 3 Gerding D N, Johnson S, Peterson L R et al.. Clostridium difficile-associated diarrhea and colitis.  Infect Control Hosp Epidemiol. 1995;  16 459-477
    CrossrefPubMedGoogle Scholar
  • 4 Warny M, Pepin J, Fang A et al.. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.  Lancet. 2005;  366 1079-1084
    CrossrefPubMedGoogle Scholar
  • 5 Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005.  MMWR Morb Mortal Wkly Rep. 2005;  54 1201-1205
    PubMedGoogle Scholar
  • 6 Hurley B W, Nguyen C C. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea.  Arch Intern Med. 2002;  162 2177-2184
    CrossrefPubMedGoogle Scholar
  • 7 Cleary R K. Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis and treatment.  Dis Colon Rectum. 1998;  41 1435-1449
    PubMedGoogle Scholar
  • 8 Viscidi R, Wiley S, Bartlett J G. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.  Gastroenterology. 1981;  81 5-9
    PubMedGoogle Scholar
  • 9 Oldfield III E C. Clostridium difficile-associated diarrhea: resurgence with a vengeance.  Rev Gastroenterol Disord. 2006;  6 79-96
    PubMedGoogle Scholar
  • 10 Hecht J R, Olinger E J. Clostridium difficile colitis secondary to intravenous vancomycin.  Dig Dis Sci. 1989;  34 148-149
    CrossrefPubMedGoogle Scholar
  • 11 Muto C A, Pokrywka M, Shutt K et al.. A large outbreak of Clostridium difficile-associated diarrhea with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.  Infect Control Hosp Epidemiol. 2005;  26 273-280
    CrossrefPubMedGoogle Scholar
  • 12 Pepin J, Saheb N, Coulombe M A et al.. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.  Clin Infect Dis. 2005;  41 1254-1260
    CrossrefPubMedGoogle Scholar
  • 13 Khurana A, Vinayek N, Recco R A et al.. The incidence of Clostridium difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute care facility.  Clin Infect Dis. 2004;  39 602-603
    CrossrefPubMedGoogle Scholar
  • 14 Noren T. Outbreak from a high-toxin intruder: Clostridium difficile. Comment on: Lancet 2005;366:1079-1084.  Lancet. 2005;  366 1053-1054
    CrossrefPubMedGoogle Scholar
  • 15 Pepin J, Valiquette L, Alary M E et al.. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.  CMAJ. 2004;  171 466-472
    PubMedGoogle Scholar
  • 16 Vesoulis Z, Williams G, Matthews B. Pseudomembranous enteritis after proctocolectomy.  Dis Colon Rectum. 2000;  43 551-554
    CrossrefPubMedGoogle Scholar
  • 17 Gonenne J, Pardi D S. Clostridium difficile: an update.  Compr Ther. 2004;  30 134-140
    PubMedGoogle Scholar
  • 18 Schroeder M S. Clostridium difficile-associated diarrhea.  Am Fam Physician. 2005;  71 921-928
    PubMedGoogle Scholar
  • 19 Bricker E, Garg R, Nelson R et al.. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.  Cochrane Database Syst Rev. 2005;  25(1) CD004610
    PubMedGoogle Scholar
  • 20 Alcantara C S, Guerrant R L. Update on Clostridium difficile infection.  Curr Gastroenterol Rep. 2000;  2 310-314
    PubMedGoogle Scholar
  • 21 Dendukuri N, Costa V, McGregor M, Brophy J M. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review.  CMAJ. 2005;  173 167-170
    PubMedGoogle Scholar
  • 22 McFarland L V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.  Am J Gastroenterol. 2006;  101 812-822
    CrossrefPubMedGoogle Scholar
  • 23 Bowden Jr T A, Mansberger Jr A R, Lykins L E. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis.  Am Surg. 1981;  47 178-183
    PubMedGoogle Scholar
  • 24 Schwan A, Sjolin S, Trottestam U et al.. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces.  Scand J Infect Dis. 1984;  16 211-215
    PubMedGoogle Scholar
  • 25 Persky S E, Brandt L J. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through the colonoscope.  Am J Gastroenterol. 2000;  95 3283-3285
    PubMedGoogle Scholar
  • 26 Aas J, Gessert C E, Bakken J S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.  Clin Infect Dis. 2003;  36 580-585
    CrossrefPubMedGoogle Scholar
  • 27 Huebner E S, Surawicz C M. Treatment of recurrent Clostridium difficile diarrhea.  Gastroenterol Hepatol. 2006;  2 203-208
    PubMedGoogle Scholar
  • 28 Grundfest-Broniatowski S, Quader M, Alexander F et al.. Clostridium difficile colitis in the critically ill.  Dis Colon Rectum. 1996;  39 619-623
    PubMedGoogle Scholar
  • 29 Trudel J L, Deschenes M, Mayrand S et al.. Toxic megacolon complicating pseudomembranous enterocolitis.  Dis Colon Rectum. 1995;  38 1033-1038
    CrossrefPubMedGoogle Scholar
  • 30 Dallal R M, Harbrecht B G, Boujoukas A J et al.. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.  Ann Surg. 2002;  235 363-372
    CrossrefPubMedGoogle Scholar
  • 31 Jobe B A, Grasley A, Deveney K E et al.. Clostridium difficile colitis: an increasing hospital-acquired illness.  Am J Surg. 1995;  169 480-483
    CrossrefPubMedGoogle Scholar
  • 32 Lipsett P A, Samantaray D K, Tam M L et al.. Pseudomembranous colitis: a surgical disease?.  Surgery. 1994;  116 491-496
    PubMedGoogle Scholar
  • 33 Medich D S, Lee K KW, Simmons R L et al.. Laparotomy for fulminant pseudomembranous colitis.  Arch Surg. 1992;  127 847-853
    PubMedGoogle Scholar
  • 34 Morris J B, Zollinger R M, Stellato T A. The role of surgery in antibiotic-induced pseudomembranous enterocolitis.  Am J Surg. 1990;  160 535-539
    CrossrefPubMedGoogle Scholar

Judith L TrudelM.D. 

Division of Colon and Rectal Surgery, Department of Surgery, University of Minnesota

393 Dunlap Ave. North, #500, St. Paul, MN 55104

eMail: jtrudel@colonrectal.org